Financial Times Ukraine news

2021-02-08 20:44:05 Iceland became one of the first European countries to start opening up society again after the second wave of Covid-19, as it reaped the rewards of having the region’s lowest infection rate.

After months of missed targets and criticism, the spread of the Covid-19 variant first identified in South Africa poses the ultimate challenge for England’s test and trace system. Take a look at our coronavirus tracker for the latest figures on infections and fatalities.

At least 130,746,061 doses of coronavirus vaccines have been administered around the world, data from 83 countries show. Take out a trial subscription to follow our global vaccine tracker.

We’ll be back tomorrow to bring you more free-to-read coverage of the coronavirus outbreak. Open / Comment

2021-02-05 11:34:47 Many in France do not want to vaccinate at all, while others complain Emmanuel Macron's government is vaccinating too slowly. The split has raised questions about the president's chances of re-election next year.

Johnson & Johnson has filed an application seeking emergency use authorisation for its single-shot Covid-19 vaccine with the Food and Drug Administration in the US. Here is our tracker, where you can find the latest on the global race to inoculate.

While conspiracy theorists once seemed alien to us, they are now our uncles and aunts, sisters and brothers — even our partners. Conspiracy theory thrives in uncertain times, such as during a pandemic. Take out a trial subscription to read more. Open / Comment

2021-02-04 17:00:21 It took a year to reach 100 million confirmed cases worldwide. It's taken six weeks to give out 100 million doses of the vaccine. Read about the latest vaccine milestone.

Denmark is to launch a coronavirus passport by the end of this month to help business travel. Take out a subscription trial and read the latest.

Switzerland’s medical regulator has said it cannot authorise use of the Oxford/AstraZeneca Covid-19 vaccine based on the available trial data. Read more on the state of the vaccine. Open / Comment

2021-02-02 17:04:21 The more infectious variant dominating coronavirus infection in the UK is evolving further mutations, which scientists say could make existing vaccines less effective at preventing infection.

Pfizer now expects about $15bn in revenue this year from its Covid-19 vaccine developed with BioNTech, as it benefits from having the first shot approved in the west.

Russia’s flagship vaccine Sputnik V has shown 91.6% efficacy against symptomatic Covid-19 in clinical trials. It's only the third with efficacy of more than 90%. Take out a trial subscription to read more. Open / Comment

2021-02-01 19:23:36 When the Covid-19 pandemic started a year ago the UK had plenty of scientific expertise in vaccines but very little industrial capacity to make them. Since then the UK has become a global leader in buying and distributing vaccines. How did it do it? We take a look at the supply chain - in graphics.

Should Covid vaccines be mandatory at work? A few companies have introduced ‘no jab, no job’ policies, but it is unclear if such steps are lawful.

The EU’s failure to deliver Covid-19 vaccines at pace is a major political scandal, writes FT columnist Gideon Rachman. Take out a trial subscription to read how Brussels bureaucrats lacked the necessary expertise in health and procurement.

We’ll be back tomorrow to bring you more free-to-read coverage of the coronavirus outbreak. Open / Comment

2021-01-30 00:29:54 Europe's sluggish vaccination campaign received a boost when AstraZeneca secured EU regulatory approval for its coronavirus vaccine for all individuals aged 18 and over.

Hospitals in Dubai are feeling the strain as cases surge in the party destination and Vietnam is rushing to contain an outbreak of the more contagious Covid variant in the north of the country. Follow our global tracker for the latest figures on infections and fatalities.

We'll be back on Monday to bring you more free-to-read coverage of the coronavirus outbreak. Open / Comment

2021-01-29 16:18:44 Breaking news: Johnson & Johnson’s coronavirus vaccine has shown 66% efficacy at preventing moderate and severe Covid-19, according to interim data published from a phase-3 trial of the first single-dose vaccine. Open / Comment

2021-01-28 20:12:27 The EU and AstraZeneca are fighting over how to interpret the contract they signed for the supply of Covid-19 vaccines to the bloc. Our contributing editor David Allen Green reflects on what this conflict shows to the world: ‘public supply contracts should always be in the public domain.’

Listen to our interview with the UN secretary-general António Guterres about the organisation’s priorities this year, including the pandemic and climate change.

The World Economic Forum is under way, and on day four India’s prime minister Narendra Modi promised that the country would manufacture more coronavirus vaccines. Take out our subscription trial to read our full story on Modi’s speech.

We’ll be back tomorrow to bring you more free-to-read coverage of the coronavirus outbreak. Open / Comment

2021-01-28 16:34:41 Breaking News: German authorities have recommended blocking use of the AstraZeneca vaccine for over-65s, saying that there is not enough data available for it. Open / Comment

2021-01-27 19:53:46 Disruption from the pandemic has created plenty of 'accidental landlords' — homeowners with an empty property they could potentially rent out. But should they? Listen to our podcast for expert advice.

The EU is preparing to put in place tighter rules on exports of coronavirus vaccines. What is being proposed? And what impact will the measures have?

It was the fastest vaccine development in history. But now pharmaceutical companies are preparing to do it all over again. Can drug makers respond fast enough to Covid variants? Take out a trial subscription to find out.

We'll be back tomorrow to bring you more free-to-read coverage of the coronavirus outbreak. Open / Comment